logo
logo
Sign in

The Nutraceuticals Is Fastest Growing Segment Fueling The Growth Of Intravenous Solutions Market

avatar
Gauri Cmi
The Nutraceuticals Is Fastest Growing Segment Fueling The Growth Of Intravenous Solutions Market

The Nutraceuticals Is Fastest Growing Segment Fueling The Growth Of Intravenous Solutions Market

Intravenous solutions or IV fluids are used for fluid replacement and correct electrolyte imbalances through intravenous administration. IV solutions help provide essential nutrients and fluids to dehydrated or malnourished patients.

 

The Intravenous Solutions Market is estimated to be valued at US$ 577228 Mn in 2023 and is expected to exhibit a CAGR of 10% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market key trends:

One of the major trends fueling the growth of the intravenous solutions market is the growing popularity of nutritional supplements and nutraceutical products in IV formulations. Several companies are developing intravenous nutraceutical solutions with enriched formulations containing vitamins, minerals, proteins, amino acids, botanical extracts, and other nutrients meant for therapeutic benefits beyond basic hydration. For example, IV vitamin therapy uses intravenous administration of various vitamins and is gaining widespread acceptance for its quick absorption and utilization by cells compared to oral supplements. The growing demand for advanced IV solutions integrated with healthcare nutrition is expected to drive the market during the forecast period.

Segment Analysis

The global intravenous solutions market is segmented on the basis of type, application, end use, and geography. By type, the market is classified into total parenteral nutrition, peripheral parenteral nutrition, intravenous solutions. The total parenteral nutrition segment dominated the market in 2022 due to rising incidence of malnutrition.

Key Takeaways

The Global Intravenous Solutions Market Size is expected to witness high growth, exhibiting CAGR of 10% over the forecast period, due to increasing prevalence of chronic diseases.

Regional analysis

North America dominated the intravenous solutions market in 2022 due to increasing adoption of parenteral nutrition in the region. The market in Asia Pacific is expected to grow at the fastest pace during the forecast period owing to rising healthcare spending and availability of low-cost solutions.

Key players

Key players operating in the intravenous solutions market are Baxter International Inc., ICU Medical. Inc, B. Braun Melsungen Ag, Grifols, S.A., Fresenius Kabi USA, LLC, Vifor Pharma Management Ltd, JW Life Science, Amanta Healthcare, Axa Parenterals Ltd, and Salius Pharma Private Limited, Pfizer, Inc, Otsuka Pharmaceutical Co., Ltd, Ajinomoto Co., Inc., B. Braun Melsungen AG, Soxa Formulations & Research Pvt.Ltd, Sichuan Kelun Pharmaceutical Co Ltd.

 

Explore More Information On This Topic @ https://www.pressreleasebulletin.com/intravenous-solutions-market-analysis/


collect
0
avatar
Gauri Cmi
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more